FM regimen: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{SI}} {{CMG}}; {{AE}} {{AV}} {{SK}} R-FM Regimen; Rituximab-Fludarabine-Mitoxantrone Regimen ==Overview== {{PAGENAME}} refers to a regimen consisting of rituxi...")
 
No edit summary
Line 6: Line 6:


==Overview==
==Overview==
{{PAGENAME}} refers to a regimen consisting of [[rituximab]], [[fludarabine]] and [[mitoxantrone]] used for the treatment of indolent [[non-Hodgkin's lymphoma]].<ref name="pmid15159414">{{cite journal| author=Zinzani PL, Pulsoni A, Perrotti A, Soverini S, Zaja F, De Renzo A et al.| title=Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma. | journal=J Clin Oncol | year= 2004 | volume= 22 | issue= 13 | pages= 2654-61 | pmid=15159414 | doi=10.1200/JCO.2004.07.170 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15159414 }} </ref>
{{PAGENAME}} refers to a regimen consisting of [[rituximab]], [[fludarabine]] and [[mitoxantrone]] used for the treatment of indolent [[non-Hodgkin's lymphoma]].<ref name="pmid15159414">{{cite journal| author=Zinzani PL, Pulsoni A, Perrotti A, Soverini S, Zaja F, De Renzo A et al.| title=Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma. | journal=J Clin Oncol | year= 2004 | volume= 22 | issue= 13 | pages= 2654-61 | pmid=15159414 | doi=10.1200/JCO.2004.07.170 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15159414 }} </ref>


==Regimen==
==Regimen==
{{chemo|R|Rituximab}}


{{chemo|R|Rituximab}}
{{chemo|F|Fludarabine}}
{{chemo|F|Fludarabine}}
{{chemo|M|Mitoxantrone}}
{{chemo|M|Mitoxantrone}}
==Indications==
==Indications==
*[[Non-Hodgkin's lymphoma]]<ref name="pmid15159414">{{cite journal| author=Zinzani PL, Pulsoni A, Perrotti A, Soverini S, Zaja F, De Renzo A et al.| title=Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma. | journal=J Clin Oncol | year= 2004 | volume= 22 | issue= 13 | pages= 2654-61 | pmid=15159414 | doi=10.1200/JCO.2004.07.170 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15159414 }} </ref>
*[[Non-Hodgkin's lymphoma]]<ref name="pmid15159414">{{cite journal| author=Zinzani PL, Pulsoni A, Perrotti A, Soverini S, Zaja F, De Renzo A et al.| title=Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma. | journal=J Clin Oncol | year= 2004 | volume= 22 | issue= 13 | pages= 2654-61 | pmid=15159414 | doi=10.1200/JCO.2004.07.170 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15159414 }} </ref>


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}


[[Category:Chemotherapy regimens]]
[[Category:Chemotherapy regimens]]

Revision as of 19:32, 30 March 2015

WikiDoc Resources for FM regimen

Articles

Most recent articles on FM regimen

Most cited articles on FM regimen

Review articles on FM regimen

Articles on FM regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on FM regimen

Images of FM regimen

Photos of FM regimen

Podcasts & MP3s on FM regimen

Videos on FM regimen

Evidence Based Medicine

Cochrane Collaboration on FM regimen

Bandolier on FM regimen

TRIP on FM regimen

Clinical Trials

Ongoing Trials on FM regimen at Clinical Trials.gov

Trial results on FM regimen

Clinical Trials on FM regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on FM regimen

NICE Guidance on FM regimen

NHS PRODIGY Guidance

FDA on FM regimen

CDC on FM regimen

Books

Books on FM regimen

News

FM regimen in the news

Be alerted to news on FM regimen

News trends on FM regimen

Commentary

Blogs on FM regimen

Definitions

Definitions of FM regimen

Patient Resources / Community

Patient resources on FM regimen

Discussion groups on FM regimen

Patient Handouts on FM regimen

Directions to Hospitals Treating FM regimen

Risk calculators and risk factors for FM regimen

Healthcare Provider Resources

Symptoms of FM regimen

Causes & Risk Factors for FM regimen

Diagnostic studies for FM regimen

Treatment of FM regimen

Continuing Medical Education (CME)

CME Programs on FM regimen

International

FM regimen en Espanol

FM regimen en Francais

Business

FM regimen in the Marketplace

Patents on FM regimen

Experimental / Informatics

List of terms related to FM regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: R-FM Regimen; Rituximab-Fludarabine-Mitoxantrone Regimen

Overview

FM regimen refers to a regimen consisting of rituximab, fludarabine and mitoxantrone used for the treatment of indolent non-Hodgkin's lymphoma.[1]

Regimen

RRituximab

FFludarabine

MMitoxantrone

Indications

References

  1. 1.0 1.1 Zinzani PL, Pulsoni A, Perrotti A, Soverini S, Zaja F, De Renzo A; et al. (2004). "Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma". J Clin Oncol. 22 (13): 2654–61. doi:10.1200/JCO.2004.07.170. PMID 15159414.